Skip to main content

Fiscal Wizard · Single-issue tearsheet

VVOS / Jun 21, 2026 Run #7293

VVOS

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Composite verdict

F 13.6 / 100
Bearish setup · Trend Following 15 drivers · 6 gates blocking
  • Vortex Signal
  • 52-Week Proximity
  • Coppock Curve
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 98th of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: volatile downtrend
Bull 0%Evidence: High · 20 signals100% Bear
Momentum Bearish 3Mean-reversion Neutral 47
  • Late-stage trendTrend signals have been live for 210 bars — past the ~60-bar window; momentum edge decays and can reverse late in a move. (medium confidence)
Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

27.3 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Days Sales Outstanding 99
Greenblatt EY 0
Asset Turnover 76
Return on Capital Employed 0
Gross Margin 75
Free Cash Flow Yield 0

Technicals Bearish

0.0 / 100

Bearish setup leads (Vortex Signal, 52-Week Proximity, Coppock Curve); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
52-Week Proximity 9
Vortex Signal 10
Coppock Curve 13

Risk Gates

6 blocking 4 caution

6 guards active, 21 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for VVOS.